Announce Date | 12/01/2022 |
EPS Normalized Actual | $-0.14 In Line |
EPS GAAP Actual | $-0.14 In Line |
Revenue Actual | $0.274569B |
Revenue Surprise | Beat by $274.569M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-13.41494 |
EPS GAAP Estimate | $-13.41494 |
Revenue Estimate | $0.059043939B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2025 | -24.9995 | -0.07 | -24.9995 | -24.9995 | 0 |
Mar 2024 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2022 (Sep 2022) | -1.09824 | -1.09824 | 0.274569B | 100% | 274.57M |
FQ2 2022 (Jun 2022) | -0.81 | -0.81 | 0.31506B | 100% | 315.06M |
FQ1 2022 (Mar 2022) | -1.485 | -1.485 | 0.249857B | 100% | 249.86M |
FQ2 2019 (Jun 2019) | -0.701538 | -0.701538 | 0.188951B | 100% | 188.95M |
FQ3 2019 (Sep 2019) | -1.49559 | -1.49559 | 0.170594B | 100% | 170.59M |
FQ4 2019 (Dec 2019) | -1.94949 | -1.94949 | 0.254086B | 100% | 254.09M |
FQ1 2020 (Mar 2020) | -0.3939 | -0.3939 | 0.156606B | 100% | 156.61M |
FQ2 2020 (Jun 2020) | -0.6075 | -0.6075 | 0.238438B | 20.75% | 238.44M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-13.41494
Consensus Revenue Estimates
0.059043939B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | -15.08605 | -- | -15.08605 | -15.08605 | 1 |
FQ1 2027 (Mar 2027) | -1.50446 | -- | -1.50446 | -1.50446 | 1 |
FQ4 2026 (Dec 2026) | -1.47205 | -- | -1.47205 | -1.47205 | 0 |
FQ3 2026 (Sep 2026) | -1.47205 | -- | -1.47205 | -1.47205 | 0 |
FQ2 2026 (Jun 2026) | -1.47205 | -- | -1.47205 | -1.47205 | 9 |
FQ1 2026 (Mar 2026) | -1.41683 | -- | -1.41683 | -1.41683 | 9 |
FQ4 2025 (Dec 2025) | -1.40196 | -- | -1.40196 | -1.40196 | 6 |
FQ3 2025 (Sep 2025) | -9.53601 | -- | -9.53601 | -9.53601 | 6 |
FQ2 2025 (Jun 2025) | -13.41494 | -- | -13.41494 | -13.41494 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Jun 2027) | 0.33B | -- | 0.33B | 0.33B | 1 |
FQ1 2027 (Mar 2027) | 0.33B | -- | 0.33B | 0.33B | 1 |
FQ4 2026 (Dec 2026) | 0.32B | -- | 0.32B | 0.32B | 0 |
FQ3 2026 (Sep 2026) | 0.32B | -- | 0.32B | 0.32B | 0 |
FQ2 2026 (Jun 2026) | 0.32B | -- | 0.32B | 0.32B | 0 |
FQ1 2026 (Mar 2026) | 0.05B | -- | 0.05B | 0.05B | 0 |
FQ4 2025 (Dec 2025) | 0.05B | -- | 0.05B | 0.05B | 0 |
FQ3 2025 (Sep 2025) | 0.04B | -- | 0.04B | 0.04B | 0 |
FQ2 2025 (Jun 2025) | 0.06B | -- | 0.06B | 0.06B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2022 (Sep 2022) | -1.09824 | -1.09824 | 100% | |
FQ2 2022 (Jun 2022) | -0.81 | -0.81 | 100% | |
FQ1 2022 (Mar 2022) | -1.485 | -1.485 | 100% | |
FQ2 2019 (Jun 2019) | -0.701538 | -0.701538 | 100% | |
FQ3 2019 (Sep 2019) | -1.49559 | -1.49559 | 100% | |
FQ4 2019 (Dec 2019) | -1.94949 | -1.94949 | 100% | |
FQ1 2020 (Mar 2020) | -0.3939 | -0.3939 | 100% | |
FQ2 2020 (Jun 2020) | -0.6075 | -0.6075 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2022 (Sep 2022) | $0B | $0.27B | $274.57M | 100% |
FQ2 2022 (Jun 2022) | $0B | $0.32B | $315.06M | 100% |
FQ1 2022 (Mar 2022) | $0B | $0.25B | $249.86M | 100% |
FQ2 2019 (Jun 2019) | $0B | $0.19B | $188.95M | 100% |
FQ3 2019 (Sep 2019) | $0B | $0.17B | $170.59M | 100% |
FQ4 2019 (Dec 2019) | $0B | $0.25B | $254.09M | 100% |
FQ1 2020 (Mar 2020) | $0B | $0.16B | $156.61M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.24B | $238.44M | 100% |